IMPACT OF BUSULFAN, ETOPOSIDE AND HIGH-DOSE ARA-C (BEA) CONDITIONING FOR AUTOLOGOUS STEM CELL TRANSPLANTATION IN AML

被引:0
|
作者
Sanz, Jaime [1 ,2 ]
Labopin, Myriam [3 ]
Daskalakis, Michael [4 ]
Broers, A. E. C. [5 ]
Van Gorkom, Gwendolyn [6 ]
Meijer, Ellen [7 ]
Gedde-Dah, Tobias [8 ]
Montoro, Juan [1 ,2 ]
Arcese, William [9 ]
Antonio Perez-Simon, Jose [10 ]
Schaap, N. [11 ]
Maertens, Johan [12 ]
Vrhovac, Radovan [13 ]
Lanza, Francesco [14 ]
Gorin, Norbert Claude [15 ]
Mohty, Mohamad [15 ]
Ciceri, Fabio [16 ]
机构
[1] Hosp Univ & Politecn La Fe, Valencia, Spain
[2] Inst Carlos III, CIBERONC, Madrid, Spain
[3] Hosp St Antoine, EBMT Paris Off, Paris, France
[4] Univ Hosp Bern, Paediat Hematol Oncol, Bern, Switzerland
[5] Erasmus MC, Univ Med Ctr Rotterdam, Inst Canc, Rotterdam, Netherlands
[6] Univ Hosp Maastricht, Maastricht, Netherlands
[7] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[8] Oslo Univ Hosp, Sect Stem Cell Transplantat, Clin Canc Med, Rikshosp, Oslo, Norway
[9] Tor Vergata Univ Rome, Stem Cell Transplant Unit, Policlin Univ Vergata, Rome, Italy
[10] Hosp Univ Virgen Rocio, Serv Hematol & Hemoterapia, Serv Andaluz Salud, Seville, Spain
[11] Nijmegen Med Ctr, Nijmegen, Netherlands
[12] Univ Hosp Gasthuisberg, Leuven, Belgium
[13] Univ Hosp Ctr Rebro, Zagreb, Croatia
[14] Osped Civile, Unita Operat Ematol, Ravenna, Italy
[15] Sorbonne Univ, Hop St Antoine, INSERM UMRs 938, Paris, France
[16] Ospedale San Raffaele srl, Haematol & BMT, Milan, Italy
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
O054
引用
收藏
页码:57 / 57
页数:1
相关论文
共 50 条
  • [21] High-Dose Idarubicin Plus Busulfan As Conditioning Regimen to Autologous Stem Cell Transplantation Improves Prognosis in Patients with Favorable and Intermediate-Risk AML
    Hong, Ming
    Liu, Wenjie
    Sun, Qian
    Sun, Qian
    Qian, Sixuan
    Li, Jianyong
    BLOOD, 2022, 140 : 12926 - 12927
  • [22] EFFICACY OF HIGH-DOSE AND INTERMEDIATE-DOSE ARA-C IN PATIENTS WITH SECONDARY AML
    LEITHA, T
    JAGER, U
    SCHWARZINGER, I
    BOGNAR, H
    BETTELHEIM, P
    GEISSLER, K
    HINTERBERGER, W
    KOS, M
    PABINGER, I
    PANZER, S
    NEUMANN, E
    LECHNER, K
    BLUT, 1986, 53 (03): : 141 - 141
  • [23] Busulfan and melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma
    Jung, Sung-Hoon
    Lee, Je-Jung
    Kim, Jin Seok
    Min, Chang-Ki
    Kim, Kihyun
    Choi, Yunsuk
    Eom, Hyeon-Seok
    Joo, Young Don
    Kim, Sung-Hyun
    Kwak, Jae-Yong
    Kang, Hye Jin
    Lee, Jae Hoon
    Lee, Ho Sup
    Mun, Yeung-Chul
    Moon, Joon Ho
    Sohn, Sang Kyun
    Park, Seong Kyu
    Park, Yong
    Shin, Ho-Jin
    Yoon, Sung-Soo
    BONE MARROW TRANSPLANTATION, 2018, 53 : 262 - 263
  • [24] Autologous peripheral blood stem cell transplant using busulfan, etoposide, high dose Ara-C, and G-CSF priming as conditioning regimen in patients with acute myeloid leukemia in first complete remission
    Moscardo, F.
    Diaz Mediavilla, J.
    de la Rubia, J.
    Fernandez, P.
    Rayon, C.
    Canigral, G.
    Arias, J.
    Palomera, L.
    Bello, J. L.
    Alcala, A.
    Sayas, M. J.
    Burgaleta, C.
    Mateos, M.
    Amador, L.
    Perez, M.
    Fernandez, R.
    Garcia, J.
    Martin, M. V.
    Roman, A.
    Queizan, J. A.
    Fernandez, J.
    Sanz, M. A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 9 - 9
  • [25] High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma
    Benson, Don M., Jr.
    Elder, Patrick J.
    Lin, Thomas S.
    Blum, William
    Penza, Sam
    Avalos, Belinda
    Copelan, Edward
    Farag, Sherif S.
    LEUKEMIA RESEARCH, 2007, 31 (08) : 1069 - 1075
  • [26] CELL KINETIC ASPECTS OF HIGH-DOSE THERAPY WITH ARA-C
    SMETS, LA
    CYTOMETRY, 1981, 2 (02): : 128 - 128
  • [27] Highdose Ara-C/Idarubicin induction and high dose Etoposide/Cytoxan intensification in AML.
    Kurian, S
    Qazilbash, MH
    Lynch, JP
    Beall, CL
    Weisenborn, R
    Bunner, P
    Hobbs, G
    Auber, M
    Ericson, SG
    BLOOD, 2000, 96 (11) : 213B - 213B
  • [28] HIGH-DOSE ARA-C AND ETOPOSIDE IN THE TREATMENT OF REFRACTORY OR RELAPSING ACUTE-LEUKEMIA
    FREUND, M
    LINK, H
    DIEDRICH, H
    WILKE, JJ
    SCHMOLL, HJ
    POLIWODA, H
    BLUT, 1987, 55 (04): : 215 - 215
  • [29] HIGH-DOSE ARA-C RELATED LEUKOENCEPHALOPATHY
    HWANG, TL
    YUNG, WKA
    LEE, YY
    BORIT, A
    FIELDS, WS
    JOURNAL OF NEURO-ONCOLOGY, 1986, 3 (04) : 335 - 339
  • [30] High-dose etoposide in allogeneic stem cell transplantation
    Øystein Bruserud
    Håkon Reikvam
    Astrid Olsnes Kittang
    Aymen Bushra Ahmed
    Tor Henrik Anderson Tvedt
    Malvin Sjo
    Kimberley Joanne Hatfield
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 765 - 782